Leading scientific and educational center of Russia (10 % of HIGHER EDUCATION institutions in the Russian Federation)
Fourth population and second largest city territory in Europe
The city with stable economic position, steady GRP growth and good level of direct federal and international investments
One of the largest centers of tourism in Europe (about 5 million tourists annually)
The city of peer possibilities with the transparent legislation for business dealing Gravity center for qualified personnel (40% from economically active population with higher education)
The leading industrial centre of Russia
Saint-Petersburg
Advanced mechanisms of investment activity stimulation (growth of international investments since 2003 – 8 times, 6,8% share in the Russian Federation)
Largest Russian seaport processing more than 20 % of total Russian seaport turnover
Center of modern innovative industry (17,3% in total high technology sector in the Russian Federation)
Federal Initiative: Strategy of medical industry development in Russian Federation for the period till 2020
Strategy of pharmaceutical industry development in Russian Federation for the period till 2020
Federal state program «Development of pharmaceutical and medical industries in Russian Federation»
Coordination program of biotechnologies development in Russian Federation for the period till 2020
State Initiatives: Recent changes in federal legislation allowing manufacturing ready forms along with research activities in special economic zones.
Local concept of pharmaceutical cluster development adopted by Saint-Petersburg Government
New Saint-Petersburg legislation resolves following preferences for 5 years period
Forming of coordination council on Saint-Petersburg pharmaceutical cluster development
Level of investments – from 800 million rubles, profit tax reduce to – 13,5%, wealth tax – 0%, reduced real estate rental payments within (re)construction period for pharmaceutical companies
Forming of Self-regulatory organization «Medical and pharmaceutical projects. XXI century»
«Noidorf» SEZ Section Laboratory complex: Biocad, Vertex, Geropharm Manufacture: Biocad Prospect: Business incubator, R&D projects
«Novo-Orlovskoe» SEZ Section Area is 110 hectares. Manufacture: Immuno-Gem, Pharmasintez, Vital Development, Novartis, Vertex. Prospect: laboratories, manufacture, R&D.
SEZ “Novo-Orlovskoe"
City centre Ring Road
SEZ “Noidorf"
«Pushkin» Industrial zone Area is 18,2 hectares, volume of investment in developing infrastructure is 13,6 mln. euro. Manufacture: Geropharm, PharmHolding, Samson-Med, Neon
13 investment projects have been set up, with a total amount of investment of over 700 mln. euro
Ring Road Airport
IZ “Pushkin"
Federal legislation provides tax privileges and customs preferences to residents of special economic zones
Payment immunity for technological plug-in to power supply networks
Infrastructure (Full land engineering)
Free Preferential
customs
rent
area
rates
Possibility of redemption of land plots on construction completing
Tax privileges
Reduction of investor expenses up to 30% 34%
Till 2026
Till 2018
In the Russian Federation 20% 15,5%
14%
18%
Profit tax
For 5 years period
For 5 years period 0%
Insurance payments
In SEZ
For 5 years period
VAT
2,2%
0%
Wealth tax
1,5%
0%
Real estate tax
For 5 years period
0% Transportation tax
The administrative building: Total area is 14,3 thous sq. m with a free lay-out: offices, meeting rooms, conference facilities.
Laboratory complex: Industrial platform: Total area is 4,7 Hectares (biological preparations, monoclonal antibodies)
Advantages: Favorable geographical location (affinity to the airport, Seaport, city of Peterhof) Research infrastructure (including free lab space) Good platform to organize thematic conferences and
exhibitions
The basic platform for R&D and greenfield projects location Total amount of investment is 310 mln euro
2
4
Administrative, business centre with the expocenter
3
Office building
1
5
Transfer technologies center with business incubator
Innovative centre
Main infrastructure objects: 1.Administrative and business centre with the expocentre, total area of 25 510 sq.m. 2.Innovative centers № 1,2, total area of 30 000 sq. m. 3.The centre of technology transfer with business incubator, area of 15 143 sq.m. 4.Customs infrastructure, total area of 1450 sq.m. with a protection of territory of 8 km extent 5.Roads length is 5,35 km; and the engineering networks
Residents SEZ «Novo-Orlovskoe»
December, 17th Novartis AG signed the MOU with the City of Saint-Petersburg Government
The partnership in three key spheres
Building of full-scale pharmaceutical manufacturing enterprise
Partnership on research and development
Development of public health services
Half a billion US dollars investments for 5 years. More than 350 new qualified workplaces
City investment in infrastructure are estimated in 542 million RUB.
FREE PLOT – 5 hа
The Company name
Production
Samson-Med
Pharmaceutical drug on the basis of natural drugs
Geropharm
Original preparations and Import replacement generics
Neon
Pharmaceutical drug and injections
Pharm-Holding
Peptide preparations
New Saint-Petersburg legislation resolves following preferences for 5 years period: level of investments - from 800 million rubles, profit tax reduce to - 13,5%, wealth tax - 0 %, reduced real estate rental payments within (re)construction period for pharmaceutical companies.
Scientific and higher educational establishments activly participating in creation pharmaceutical cluster The Saint-Petersburg state chemical-pharmaceutical Academy - pharmaceutical technologies The Saint-Petersburg state University – the separate status at the Government of the Russian Federation, medical faculty, biological faculty The Saint-Petersburg state Institute of technology - synthesis of biologically-active substances, manufacture of substances The Saint-Petersburg state Medical University of academic Pavlov - pharmacology, pre-clinical studies, clinical researches
The Saint-Petersburg state Polytechnical University - the analytical chemical and biological center, nanotechnologies The state scientific research institute of especially pure biological preparations – the biotechnological center, a versatile researchand-production complex Institute of cytology of the Russian Academy of Sciences - pharmacology on cellular models Toxicology institute - center of science in the field of toxicological researches; basic researches in the field of toxicology, pharmaceutical chemistry and pharmacology Influenza Scientific research institute - vaccines, technological laboratory, researches in the field of virology and working out of the questions bound to an etiology, diagnostics, epidemiology, clinic and preventive maintenance of a flu and other acute respiratory infections, creation of agents of their preventive maintenance and treatment The Saint-Petersburg institute of pharmacy (“Inter-regional Center «Adaptogen»” and the Saint-Petersburg state medical Academy of Mechnikov) - carrying out pre-clinical studies of pharmaceutical preparations, specialized foodstuff, biologically-active bonds, cosmetic production The Saint-Petersburg state medical academy of Mechnikov - the research center including laboratories of morphology and genetics, biochemistry, immunology, physiology, mathematical modeling, the epidemiological analysis
The arrangement on inclusion of the St.-Petersburg state chemical-pharmaceutical academy in program Tempus realized by the European Union in the Russian Federation in sphere of preparation of experts on GMP is reached. Saint-Petersburg Chemical-Pharmaceutical Academy Is the leading educational center of the Russian Federation on preparation . Process engineers on industrial production of medicines of a various origin. Saint-Petersburg State Institute of Technology The center of science of chemistry recognized in the world, chemical technology, biotechnology, Nanotechnologies, cybernetics and technics. A wide spectrum of synthesis methods active pharmaceutical ingredients. Trial manufacture of substances. Manufacture of substances according to requirements GMP. A Professional training for science centers and the industrial enterprises.
Saint-Petersburg State I.P.Pavlov Medical University
Pre-clinical researches (research and studying of new molecules and medicinal forms), Transmitting researches, (1 place according to Roszdravnadzor Clinical researches, by quantity of clinical researches) Pharmacoepidemiological and pharmacoeconomical researches, A professional training (GLP, GCP, GSP, demonstrative medicine) Saint-Petersburg State Polytechnic University
Bioanalytical researches at world level according to requirements FDA and GLP, Performance of hi-tech research projects on working out and studying of active pharmaceutical substances of a natural and synthetic origin, Preparation of highly skilled experts in the field of molecular biology
«Novo-Orlovskoe» SEZ Section The area is 110 hectares
Universities: - Institute of Technology - Chemical and Pharmaceutical Academy - Pavlov Medical University - Polytechnic University
Laboratory:
«Pushkin» Industrial zone The area is18,2 hectares The volume of investment in developing infrastructure is 13,6 mln euro
Manufacture:
«Noidorf» SEZ Section The area is 18,9 hectares Research institute: - Research institute of experimental medicine - Research institute of influenza
- Research institute of especially pure biological products
The first IPhEB forum was held in St. Petersburg on 26 - 28 April, 2011 with the support of the Government of Saint-Petersburg. The Minister for Industry and Trade of the Russian Federation and the Governor of Saint-Petersburg have participated in the IPhEB. ďƒ˜787 Russian and foreign participants in 2011 ďƒ˜ Partner countries - India and Finland, participation of Israel is also planned
Key targets of the Life Sciences Invest. Partnering Russia are:
It is an alliance of the Life Sciences companies who connect their development strategies in Russia with initiatives of Saint-Petersburg to form the pharmaceutical and medical cluster
Targets are to: • Implement the initiative of the Government of St.-Petersburg on Cluster creation and boosting • Promote implementation of participating companies’ investment projects • Develop international partnering within the Cluster • Improve the legal environment in Russia (licensing, registration etc.) • Promote cluster production to the Russian and international market
Aims are to: • Provide expert services for participating companies (supervising investment projects, public purchase, marketing, PR, assisting in target programs participation) • Develop partnership with the international alliances, incl signing the agreements • Implement the infrastructural projects (Life Sciences park, Business incubator etc.)
Participating companies: • • • • •
Medical equipment, laboratory diagnostics and medical devices producing companies Local and global pharmaceutical companies Service companies (consulting, CRO, marketing) Large medical projects (proton therapy center, nuclear medicine projects) Large infrastructure development projects (life-sciences park, business incubator)
Government of Saint-Petersburg Committee for Economic Development, Industrial Policy and Trade